Articles with public access mandates - Wolfgang JostLearn more
Not available anywhere: 5
Advanced stages of PD: interventional therapies and related patient-centered care
R Krüger, R Hilker, C Winkler, M Lorrain, M Hahne, C Redecker, P Lingor, ...
Journal of neural transmission 123, 31-43, 2016
Mandates: German Research Foundation
Differentiation of atypical Parkinson syndromes
GU Höglinger, J Kassubek, I Csoti, R Ehret, H Herbst, I Wellach, J Winkler, ...
Journal of Neural Transmission 124, 997-1004, 2017
Mandates: German Research Foundation
Reduced body mass index in Parkinson’s disease: contribution of comorbid depression
M Pilhatsch, NB Kroemer, C Schneider, G Ebersbach, WH Jost, G Fuchs, ...
The Journal of nervous and mental disease 201 (1), 76-79, 2013
Mandates: German Research Foundation, Swedish Research Council
King’s Parkinson’s disease pain scale: Intercultural adaptation in the German language
WH Jost, A Rizos, P Odin, M Löhle, A Storch
Der Nervenarzt 89, 178-183, 2018
Mandates: Parkinson's UK
Validity of the DESPAR questionnaire as a new screening tool for depression in Parkinson’s disease
A Storch, Y Paelecke-Habermann, CB Schneider, WH Jost, G Fuchs, ...
Basal Ganglia 1 (2), 97-103, 2011
Mandates: German Research Foundation
Available somewhere: 19
Assessment of safety and efficacy of safinamide as a levodopa adjunct in patients with Parkinson disease and motor fluctuations: a randomized clinical trial
AHV Schapira, SH Fox, RA Hauser, J Jankovic, WH Jost, C Kenney, ...
JAMA neurology 74 (2), 216-224, 2017
Mandates: US National Institutes of Health, National Institute for Health Research, UK …
Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS)
A Storch, CB Schneider, L Klingelhöfer, P Odin, G Fuchs, WH Jost, ...
Journal of Neural Transmission 122, 1673-1684, 2015
Mandates: Parkinson's Foundation, USA
The progressive supranuclear palsy clinical deficits scale
I Piot, K Schweyer, G Respondek, M Stamelou, DescribePSP study group, ...
Movement Disorders 35 (4), 650-661, 2020
Mandates: US National Institutes of Health, German Research Foundation, Federal …
GBA-associated PD: chances and obstacles for targeted treatment strategies
G Höglinger, C Schulte, WH Jost, A Storch, D Woitalla, R Krüger, ...
Journal of Neural Transmission 129 (9), 1219-1233, 2022
Mandates: German Research Foundation, Federal Ministry of Education and Research …
A pilot prospective, multicenter observational study of dopamine agonist withdrawal syndrome in Parkinson's disease
KR Chaudhuri, A Todorova, MJ Nirenberg, M Parry, A Martin, ...
Movement Disorders clinical practice 2 (2), 170-174, 2015
Mandates: US National Institutes of Health, German Research Foundation, Swedish …
Individualized OnabotulinumtoxinA treatment for upper limb spasticity resulted in high clinician‐and patient‐reported satisfaction: long‐term observational results from the …
GE Francisco, WH Jost, G Bavikatte, DS Bandari, SFT Tang, MC Munin, ...
PM&R 12 (11), 1120-1133, 2020
Mandates: US National Institutes of Health
Intraindividual variability of nonmotor fluctuations in advanced Parkinson’s disease
M Fauser, M Löhle, G Ebersbach, P Odin, G Fuchs, WH Jost, K Chaudhuri, ...
Journal of Parkinson's Disease 5 (4), 737-741, 2015
Mandates: Parkinson's Foundation, USA
Treadmill training and physiotherapy similarly improve dual task gait performance: a randomized-controlled trial in Parkinson’s disease
H Gaßner, E Trutt, S Seifferth, J Friedrich, D Zucker, Z Salhani, W Adler, ...
Journal of Neural Transmission 129 (9), 1189-1200, 2022
Mandates: German Research Foundation, Fraunhofer-Gesellschaft
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
J Brumberg, N Schröter, G Blazhenets, L Frings, J Volkmann, C Lapa, ...
npj Parkinson's Disease 6 (1), 39, 2020
Mandates: German Research Foundation
Long‐term observational results from the ASPIRE study: OnabotulinumtoxinA treatment for adult lower limb spasticity
A Esquenazi, G Bavikatte, DS Bandari, WH Jost, MC Munin, SFT Tang, ...
PM&R 13 (10), 1079-1093, 2021
Mandates: US National Institutes of Health
Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes
N Schröter, G Blazhenets, L Frings, WH Jost, C Weiller, M Rijntjes, ...
NPJ Parkinson's disease 8 (1), 123, 2022
Mandates: German Research Foundation
Safinamide in the treatment pathway of Parkinson’s disease: a European Delphi consensus
F Stocchi, A Antonini, D Berg, B Bergmans, W Jost, R Katzenschlager, ...
npj Parkinson's Disease 8 (1), 17, 2022
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
Imaging cardiac sympathetic innervation with MIBG: linear conversion of the heart-to-mediastinum ratio between different collimators
J Brumberg, G Blazhenets, N Schröter, L Frings, WH Jost, C Lapa, ...
EJNMMI physics 6, 1-7, 2019
Mandates: German Research Foundation
Pain reduction in cervical dystonia following treatment with incobotulinumtoxinA: A pooled analysis
A Albanese, J Wissel, WH Jost, A Castagna, M Althaus, G Comes, ...
Toxins 15 (5), 333, 2023
Mandates: US National Institutes of Health
The akinetic crisis in Parkinson´ s disease-the upper end of a spectrum of subacute akinetic states
M Pötter-Nerger, C Schrader, WH Jost, G Höglinger
Journal of Neural Transmission, 1-9, 2024
Mandates: European Commission
Publication and funding information is determined automatically by a computer program